PMID- 28686208 OWN - NLM STAT- MEDLINE DCOM- 20180330 LR - 20230107 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 18 IP - 7 DP - 2017 Jul 7 TI - Structural Elements Recognized by Abacavir-Induced T Cells. LID - 10.3390/ijms18071464 [doi] LID - 1464 AB - Adverse drug reactions are one of the leading causes of morbidity and mortality in health care worldwide. Human leukocyte antigen (HLA) alleles have been strongly associated with drug hypersensitivities, and the causative drugs have been shown to stimulate specific T cells at the sites of autoimmune destruction. The structural elements recognized by drug-specific T cell receptors (TCRs) in vivo are poorly defined. Drug-stimulated T cells express TCRs specific for peptide/HLA complexes, but the characteristics of peptides (sequence, or endogenous or exogenous origin) presented in the context of small molecule drugs are not well studied. Using HLA-B*57:01 mediated hypersensitivity to abacavir as a model system, this study examines structural similarities of HLA presented peptides recognized by drug-specific TCRs. Using the crystal structure of HLA-B*57:01 complexed with abacavir and an immunogenic self peptide, VTTDIQVKV SPT5a 976-984, peptide side chains exhibiting flexibility and solvent exposure were identified as potential drug-specific T cell recognition motifs. Viral sequences with structural motifs similar to the immunogenic self peptide were identified. Abacavir-specific T cell clones were used to determine if virus peptides presented in the context of abacavir stimulate T cell responsiveness. An abacavir-specific T cell clone was stimulated by VTQQAQVRL, corresponding to HSV1/2 230-238, in the context of HLA-B*57:01. These data suggest the T cell polyclonal response to abacavir consists of multiple subsets, including T cells that recognize self peptide/HLA-B*57:01 complexes and crossreact with viral peptide/HLA-B*57:01 complexes due to similarity in TCR contact residues. FAU - Yerly, Daniel AU - Yerly D AD - Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, 3010 Bern, Switzerland. daniel.yerly@allergy.unibe.ch. FAU - Pompeu, Yuri Andreiw AU - Pompeu YA AD - Harvard Medical School, Cambridge, MA 02138, USA. Yuri_Pompeu@hms.harvard.edu. FAU - Schutte, Ryan J AU - Schutte RJ AD - Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA. rschutte@ufl.edu. FAU - Eriksson, Klara K AU - Eriksson KK AD - Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, 3010 Bern, Switzerland. klara.eriksson@allergy.unibe.ch. FAU - Strhyn, Anette AU - Strhyn A AD - Department of Microbiology and Immunology, University of Copenhagen, 1165 Kobenhavn, Denmark. astryhn@sund.ku.dk. FAU - Bracey, Austin W AU - Bracey AW AD - Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA. bracey.a@ufl.edu. FAU - Buus, Soren AU - Buus S AD - Department of Microbiology and Immunology, University of Copenhagen, 1165 Kobenhavn, Denmark. sbuus@sund.ku.dk. FAU - Ostrov, David A AU - Ostrov DA AD - Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA. ostroda@pathology.ufl.edu. LA - eng GR - R01 AI103348/AI/NIAID NIH HHS/United States PT - Journal Article DEP - 20170707 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Dideoxynucleosides) RN - 0 (Epitopes) RN - 0 (HLA-B Antigens) RN - 0 (HLA-B57 antigen) RN - 0 (Peptides) RN - 0 (Receptors, Antigen, T-Cell) RN - WR2TIP26VS (abacavir) SB - IM MH - Amino Acid Sequence MH - Crystallography, X-Ray MH - Dideoxynucleosides/*pharmacology MH - Epitopes/immunology MH - HLA-B Antigens/chemistry/immunology MH - Herpes Simplex/immunology MH - Humans MH - Peptides/chemistry/immunology MH - Receptors, Antigen, T-Cell/chemistry/immunology MH - T-Lymphocytes/drug effects/*immunology MH - Transfection PMC - PMC5535955 OTO - NOTNLM OT - Human Leukocyte Antigen OT - crystallography OT - drug hypersensitivity COIS- The authors declare no conflict of interest. EDAT- 2017/07/08 06:00 MHDA- 2018/03/31 06:00 PMCR- 2017/07/01 CRDT- 2017/07/08 06:00 PHST- 2017/04/27 00:00 [received] PHST- 2017/06/13 00:00 [revised] PHST- 2017/06/27 00:00 [accepted] PHST- 2017/07/08 06:00 [entrez] PHST- 2017/07/08 06:00 [pubmed] PHST- 2018/03/31 06:00 [medline] PHST- 2017/07/01 00:00 [pmc-release] AID - ijms18071464 [pii] AID - ijms-18-01464 [pii] AID - 10.3390/ijms18071464 [doi] PST - epublish SO - Int J Mol Sci. 2017 Jul 7;18(7):1464. doi: 10.3390/ijms18071464.